Showing results (1541-1550 of 1,569) with videos related to

Sort By:
Pageof 157
Neurologia|March 1, 2026
Neuroprimary: Assessment of teleconsultation as a single gateway to neurology from primary careS Pérez-Sánchez, M Á Quesada García, F Sánchez Fernández, et al.
Pathologie-Biologie|November 10, 2009
[Evolution of group A Rotavirus strains circulating in Tunisia over a 3-year period (2005-2007)]A Chouikha, M Ben Hadj Fredj, I Fodha, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 28, 2016
[Prostate cancer of elderly patients: Place and role of geriatric assessment]B Méry, A Vallard, S Espenel, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 22, 2026
Dihydropyrimidine dehydrogenase phenotype-guided dose individualization of fluoropyrimidine in gastrointestinal cancers: PRODIGE100-UCGI48-FUDOSE phase II studyG M Camilleri, M A Loriot, G Le Teuff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2026
Survival outcomes in POD1UM-303/InterAACT-2: a phase 3 study of retifanlimab plus carboplatin-paclitaxel in first-line advanced squamous anal cancerS Rao, E Samalin-Scalzi, L Evesque, et al.
The British Journal of Dermatology|September 21, 2020
The global burden of chronic urticaria for the patient and societyM Gonçalo, A Gimenéz-Arnau, M Al-Ahmad, et al.
Plos Biology|December 11, 2020
In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulatorsJennifer L Franks, Raquel C Martinez-Chacin, Xianxi Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2019
Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)A Adenis, J Bennouna, P L Etienne, et al.
Pageof 157